3 Stocks to Buy if You Think the Economy Is Heading for a Recession

Source Motley_fool

Key Points

  • These stocks have defensive qualities that can allow them to maintain consistent results through thick and thin.

  • They also have outstanding dividend track records.

  • 10 stocks we like better than Abbott Laboratories ›

Although broader equities have performed pretty well this year, recession fears are lingering. After all, we are still dealing with macroeconomic problems and rising inflation. For those especially worried that the economy will eventually succumb to these headwinds and enter a recession, it helps to buy shares of companies that can perform well even in the most challenging environments. Here are three of them: Abbott Laboratories (NYSE: ABT), Coca-Cola (NYSE: KO), and Walmart (NASDAQ: WMT). Read on to find out why these three stocks are excellent buys if there is a recession on the way.

Doctor and patient in a hospital room.

Image source: Getty Images.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

1. Abbott Laboratories

There are several reasons Abbott Laboratories is an excellent stock to buy ahead of a recession. First, it has a large portfolio of healthcare products across four categories: Pharmaceuticals, medical devices, nutrition, and diagnostics. Many of the products it offers remain in high demand regardless of economic conditions. For instance, in nutrition, it is a market leader in baby formula, something parents aren't going to want to stop buying, no matter what happens. Within its core medical device business, Abbott Laboratories markets a range of products that help treat serious, sometimes life-threatening conditions.

Those, too, should experience resilient demand even during recessions. Second, Abbott Laboratories has several growth drivers that could help it deliver solid financial results for a long time. The company's FreeStyle Libre franchise -- a family of continuous glucose monitoring devices for diabetes patients -- has been its main growth driver for a while and still boasts plenty of white space.

Abbott Laboratories also now has a stronger presence in the cancer screening market, another promising niche, thanks to a recent acquisition. Third, Abbott Laboratories is a fantastic dividend stock. With 54 straight years of payout increases, the healthcare giant is a Dividend King, or a corporation with at least 50 consecutive years of dividend raises. Regular payouts can help buffer market losses if a recession drags broader equities down. Abbott Laboratories hasn't performed well this year, partly due to slowing top-line growth, especially within its diagnostic and nutrition businesses.

However, recent developments (including an acquisition that boosted its diagnostics segment) can help it address these problems. The stock should remain a reliable dividend payer through the next recession and beyond.

2. Coca-Cola

Coca-Cola is a consumer staples giant with a large portfolio of beverages across practically every category known to man, including water, alcohol, sports drinks, coffee, tea, and more. The company boasts a strong brand name that allows it to command shelf space in grocery stores while nearly effortlessly attracting customers. The consumer staples industry is a highly defensive one. So, even in a recession, Coca-Cola's business should perform relatively well, as the company has demonstrated many times before.

Coca-Cola is also an innovative beverage maker that routinely launches new products (or twists on existing ones) that help it stay ahead of changing consumer demands. That can, for instance, mean introducing cheaper versions of some of its well-known brands to attract price-sensitive customers during tough economic times. All these factors -- and more -- make Coca-Cola a recession-resistant stock. And to top it all off, the company is also a Dividend King with 64 consecutive years of payout increases.

3. Walmart

Walmart, a leading U.S. retailer, is known for its Every Day Low Price (EDLP) strategy. Thanks to the company's large scale and extensive customer base, it can negotiate favorable deals with suppliers and pass those cost savings onto its customers, whether they shop directly in its stores or through online channels. Walmart is a leading e-commerce retailer, and its online retail business has been growing much faster in recent years.

We can also mention Walmart's vast footprint in the U.S.: 90% of the country's population lives within 10 miles of one of its stores. In other words, Walmart is conveniently located and offers attractive prices, making it a great place to shop, especially during a recession. That's why the company can perform relatively well even amid economic problems. Lastly, Walmart is a Dividend King, too, with 53 consecutive years of payout increases. The retail giant might suffer a bit if we head into a recession, but it should emerge in one piece and continue performing well long after.

Should you buy stock in Abbott Laboratories right now?

Before you buy stock in Abbott Laboratories, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Abbott Laboratories wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $481,750!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,352,457!*

Now, it’s worth noting Stock Advisor’s total average return is 990% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of May 21, 2026.

Prosper Junior Bakiny has positions in Walmart. The Motley Fool has positions in and recommends Abbott Laboratories and Walmart. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
MicroStrategy Shares are Performing Better than Bitcoin In 2026, But How?MicroStrategy stock is up nearly 3% at press time, trading above $137 as markets opened on March 9. Strategy just announced another 17,994 BTC purchase for $1.28 billion.The stock trades 57% lower ove
Author  Beincrypto
Mar 10, Tue
MicroStrategy stock is up nearly 3% at press time, trading above $137 as markets opened on March 9. Strategy just announced another 17,994 BTC purchase for $1.28 billion.The stock trades 57% lower ove
placeholder
3 US Stocks To Watch In Late March 2026With the US-Iran conflict reshaping global markets, oil surging past $94 a barrel, and tech infrastructure becoming a direct military target, equities across sectors are repricing risk in real time. A
Author  Beincrypto
Mar 13, Fri
With the US-Iran conflict reshaping global markets, oil surging past $94 a barrel, and tech infrastructure becoming a direct military target, equities across sectors are repricing risk in real time. A
placeholder
Goldman Sachs takes lead on SpaceX IPO as prospectus expected WednesdayGoldman Sachs will take the lead left seat for SpaceX’s initial public offering, positioning the firm as the most prominent player in what could become the biggest IPO of all time, according to CNBC Morgan Stanley comes next. BofA, Citi, and JPMorgan complete the rest of the senior positions. This brings the SpaceX IPO out...
Author  Cryptopolitan
Yesterday 02: 27
Goldman Sachs will take the lead left seat for SpaceX’s initial public offering, positioning the firm as the most prominent player in what could become the biggest IPO of all time, according to CNBC Morgan Stanley comes next. BofA, Citi, and JPMorgan complete the rest of the senior positions. This brings the SpaceX IPO out...
placeholder
Nvidia Shares Gain as Chipmaker Tops Estimates on 85% AI Revenue SurgeNvidia delivered another blockbuster quarter, beating Wall Street estimates on revenue, earnings, and data center growth as global demand for AI infrastructure accelerated.The chipmaker’s results rein
Author  Beincrypto
6 hours ago
Nvidia delivered another blockbuster quarter, beating Wall Street estimates on revenue, earnings, and data center growth as global demand for AI infrastructure accelerated.The chipmaker’s results rein
placeholder
Pundit Predicts What Will Happen To XRP When Exchanges Run Out Of SupplyXRP’s supply mechanism is one of the most controversial talking points in the crypto market. XRP exchange reserves have been falling for months, and the on-chain numbers are glaring. Now, a crypto
Author  NewsBTC
6 hours ago
XRP’s supply mechanism is one of the most controversial talking points in the crypto market. XRP exchange reserves have been falling for months, and the on-chain numbers are glaring. Now, a crypto
goTop
quote